| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |